Following the death of a 10-year-old boy from Tiruvallur district who was diagnosed with Guillain-Barre Syndrome (GBS), an autoimmune neurological disorder, health officials have said that there was ...

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.

Allergies and asthma are widespread diseases that could arise during embryonal development in the womb. A team led by Empa ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all been flattened by an awful stomach bug at some point in our lives. For ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, with disease progression ranging from slow and indolent to ...